SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer.

Meihua Jin Woo Kyung Lee DoolittleMi-Hyeon YouAhreum JangSheue-Yann ChengWon Gu KimMin Ji JeonYu-Mi Lee

Published in: Endocrine connections (2021)

SHMT2 expression is higher in thyroid cancers than normal or benign tissues and is associated with de-differentiation and poor clinical outcomes. Thus, SHMT2 might be useful as a diagnostic and prognostic marker for thyroid cancer.

Keyphrases

poor prognosis
binding protein
long non coding rna
young adults
childhood cancer